ArticleTargeted oncology2026

Posterior Reversible Encephalopathy Syndrome with Angiogenesis Inhibitors for Solid Tumours: Clues from a Disproportionality Analysis of the FDA Adverse Event Reporting System and Pharmacodynamics.

Monia Donati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.